Daptomycin 100mg | Purity Not Available
Selleck Chemicals
Daptomycin is a novel antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.
More Information Supplier PageDaptomycin is a novel antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.
More Information Supplier PageDoripenem Hydrate (S-4661) is an ultra-broad-spectrum injectable antibiotic, used to treat complicated intra-abdominal infections and complicated urinary tract infections.
More Information Supplier PageDoripenem Hydrate (S-4661) is an ultra-broad-spectrum injectable antibiotic, used to treat complicated intra-abdominal infections and complicated urinary tract infections.
More Information Supplier PageDorzolamide (MK-507, L-671152) HCl is a water-soluble, potent inhibitor of human carbonic anhydrase II and IV with Ki of 1.9 nM and 31 nM, respectively, used as anti-glaucoma agent.
More Information Supplier PageRigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Rigosertib inhibits PI3K/Akt pathway and activates oxidative stress signals. Rigosertib induces apoptosis in various cancer cells. Phase 3.
More Information Supplier PageRigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Rigosertib inhibits PI3K/Akt pathway and activates oxidative stress signals. Rigosertib induces apoptosis in various cancer cells. Phase 3.
More Information Supplier PagePatupilone (EPO906, Epothilone B) is a microtubule-stabilizing agent with EC0.01 of 1.8 μM. Phase 2.
More Information Supplier PagePatupilone (EPO906, Epothilone B) is a microtubule-stabilizing agent with EC0.01 of 1.8 μM. Phase 2.
More Information Supplier PageBMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2.
More Information Supplier PageAmonafide (NSC308847, AS1413) produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage. Phase 3.
More Information Supplier Page